Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma.
Kenessey I, Keszthelyi M, Krámer Z, Berta J, Adám A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, Szokol B, Orfi L, Kéri G, Döme B, Klepetko W, Tímár J, Tóvári J.
Kenessey I, et al. Among authors: barna g.
Curr Cancer Drug Targets. 2010 May;10(3):332-42. doi: 10.2174/156800910791190184.
Curr Cancer Drug Targets. 2010.
PMID: 20370683